ARTBIO
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98347034
- Registration number
- 8096706
- Mark type
- Stylized text
- Filed
- 08 Jan 2024
- Published for opposition
- 17 Sept 2024
- Registered
- 06 Jan 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of targeted radiation therapy; pharmaceutical preparations for use in targeted radiation therapy for the treatment of cancer; pharmaceutical preparations for the treatment of cancer
- Class 042 — Scientific and technological services: Medical and scientific research in the field of radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields oncology, cancer, and radiology; pharmaceutical and biotechnological research and development in the field of targeted radiation therapy
Owner
- ARTBIO, Inc., Cambridge, MA, US
- ARTBIO, Inc., Cambridge, MA, US
- ARTBIO, Inc., Cambridge, MA, US
Prosecution history
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 18 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Dec 2025 — USE AMENDMENT FILED
- 30 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2025 — SOU EXTENSION 1 GRANTED
- 11 May 2025 — SOU EXTENSION 1 FILED
- 29 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Dec 2024 — TEAS STATEMENT OF USE RECEIVED